文献速递其他结缔组织病

成人皮肌炎抗NXP-2抗体相关皮肤与系统表现

Cutaneous and Systemic Findings Associated With Nuclear Matrix Protein 2 Antibodies in Adult Dermatomyositis Patients.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2017-11-02

该回顾性队列分析纳入斯坦福大学门诊178例皮肌炎患者,用免疫沉淀法检测抗NXP-2抗体,检出20例(11%)。抗NXP-2抗体与男性、吞咽困难、肌痛、外周水肿和钙质沉着相关,患者皮肤炎症较轻但系统症状常较重。

要点

  • 抗NXP-2抗体见于11%成人皮肌炎患者。
  • 抗体阳性者更常见肌痛、吞咽困难、外周水肿和钙质沉着。
  • 抗体阳性者皮肤炎症较轻,Gottron征频率较低。

核心结论

  • 抗NXP-2抗体阳性皮肌炎患者具有独特的系统表型,包括肌痛、外周水肿和显著吞咽困难,尽管皮肤炎症较轻。

研究设计与样本

  • 回顾性队列分析纳入斯坦福大学门诊178例皮肌炎患者,采用关键词检索电子病历收集临床和实验室数据,用体外转录/翻译产生的NXP-2经免疫沉淀法检测抗NXP-2抗体。

主要发现

  • 178例中20例(11%)检出抗NXP-2抗体。
  • 抗NXP-2抗体与男性相关(50% vs 25%;P=0.02)。
  • 抗NXP-2抗体与吞咽困难相关(74% vs 39%;P=0.006)。
  • 抗NXP-2抗体与肌痛相关(89% vs 52%;P=0.002)。
  • 抗NXP-2抗体与外周水肿相关(35% vs 11%;P=0.016),与钙质沉着相关(37% vs 11%;P=0.007)。

关键数值与推荐

  • 抗NXP-2抗体阳性者临床无肌病性皮肌炎比例较低(5% vs 23%;P=0.08)。
  • 20例抗NXP-2抗体阳性者中5例(25%)伴发内部恶性肿瘤。
  • 抗NXP-2抗体阳性者Gottron征频率较低(44% vs 75%;P=0.012),更可能有轻度皮肤病变。

临床怎么用

  • 成人皮肌炎检出抗NXP-2抗体时,应关注吞咽困难、肌痛、外周水肿和钙质沉着等系统表现,并留意合并内部恶性肿瘤的可能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To characterize the cutaneous and systemic clinical phenotype of dermatomyositis patients with antinuclear matrix protein 2 (anti-NXP-2) antibodies. METHODS: We conducted a retrospective cohort analysis of 178 dermatomyositis patients seen at the Stanford University Clinic. An electronic chart review employing a keyword search strategy was performed to collect clinical and laboratory data. Anti-NXP-2 antibodies were assayed by immunoprecipitation using NXP-2 produced by in vitro transcription/translation. RESULTS: Antibodies to NXP-2 were detected in 20 of the 178 patients (11%). Anti-NXP-2 antibodies were associated with male sex (50% versus 25%; P = 0.02), dysphagia (74% versus 39%; P = 0.006), myalgia (89% versus 52%; P = 0.002), peripheral edema (35% versus 11%; P = 0.016), and calcinosis (37% versus 11%; P = 0.007). These patients were less likely to be clinically amyopathic (5% versus 23%; P = 0.08). Five of the 20 patients with anti-NXP-2 antibodies (25%) had an associated internal malignancy. No other cutaneous characteristics were associated with anti-NXP-2 antibodies, except a decreased frequency of Gottron's sign (44% versus 75%; P = 0.012) and a greater likelihood of having mild skin disease. CONCLUSION: Dermatomyositis patients with anti-NXP-2 antibodies have a distinct and often severe systemic phenotype that includes myalgia, peripheral edema, and significant dysphagia, despite having milder inflammatory skin disease.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Rogers A, Chung L, Li S, et al. Cutaneous and Systemic Findings Associated With Nuclear Matrix Protein 2 Antibodies in Adult Dermatomyositis Patients. Arthritis Care Res (Hoboken). 2017. PMID: 28129490. doi:10.1002/acr.23210

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。